Desq Long
Sign in

Company

Bicara Therapeutics Inc.

BCAX · CIK 0002023658

SEC FORM 4
$66,321.50

Bicara Therapeutics Inc. (BCAX)

Acquisition (code M) of 17,500 shares at $3.7898 per share.

Reporting Person Cohlhepp Ryan · Officer Title President, COO & Interim CEO · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001470831-26-000883 · filed 2026-09-10 · View filing →

SEC FORM 4
$320,052.86

Bicara Therapeutics Inc. (BCAX)

Sale of 14,058 shares at $22.7666 per share.

Reporting Person Cohlhepp Ryan · Officer Title President, COO & Interim CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001470831-26-000883 · filed 2026-09-10 · View filing →

SEC FORM 4
$80,662.93

Bicara Therapeutics Inc. (BCAX)

Sale of 3,442 shares at $23.4349 per share.

Reporting Person Cohlhepp Ryan · Officer Title President, COO & Interim CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001470831-26-000883 · filed 2026-09-10 · View filing →

SEC FORM 4
$71,058.75

Bicara Therapeutics Inc. (BCAX)

Acquisition (code M) of 18,750 shares at $3.7898 per share.

Reporting Person Cohlhepp Ryan · Officer Title President and COO · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001470831-26-000812 · filed 2026-08-12 · View filing →

SEC FORM 4
$524,533.13

Bicara Therapeutics Inc. (BCAX)

Sale of 18,750 shares at $27.9751 per share.

Reporting Person Cohlhepp Ryan · Officer Title President and COO · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001470831-26-000812 · filed 2026-08-12 · View filing →

SEC FORM 4
$37,898.00

Bicara Therapeutics Inc. (BCAX)

Acquisition (code M) of 10,000 shares at $3.7898 per share.

Reporting Person Mazumdar Claire · Officer Title Chief Executive Officer · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001470831-26-000813 · filed 2026-08-12 · View filing →

SEC FORM 4
$279,750.00

Bicara Therapeutics Inc. (BCAX)

Sale of 10,000 shares at $27.975 per share.

Reporting Person Mazumdar Claire · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001470831-26-000813 · filed 2026-08-12 · View filing →

SEC FORM 4
$47,372.50

Bicara Therapeutics Inc. (BCAX)

Acquisition (code M) of 12,500 shares at $3.7898 per share.

Reporting Person Hyep Ivan · Officer Title Chief Financial Officer · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001470831-26-000814 · filed 2026-08-12 · View filing →

SEC FORM 4
$349,591.25

Bicara Therapeutics Inc. (BCAX)

Sale of 12,500 shares at $27.9673 per share.

Reporting Person Hyep Ivan · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001470831-26-000814 · filed 2026-08-12 · View filing →